Search results for "Highlights"


 
Results 91 - 100 of about 376 for "Highlights".

Highlights

The results highlight the heterogeneity of type 2 diabetes and may help explain the differences in disease progression and response to glucose-lowering treatment seen in clinical practice, an accompanying comment
August 2019

Highlights

Incorporating intensive weight management with a low-carb diet into standard group medical visits for patients with diabetes “should be considered as an alternative, noninferior approach for glycemic management that has additional clinical
November 2019

Highlights

A recent scientific statement on diabetes and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes on outcomes in heart failure; reviews pharmacological therapy and lifestyle modification; highlights the value
June 2019

Highlights

Patients with type 1 diabetes who were randomly assigned to insulin treatment with a closed-loop system spent more time in the target glycemic range than those assigned to a sensor-augmented pump.
November 2019

Keeping tabs

The results highlight the underappreciated burden of diabetic foot hospitalizations not associated with amputation, the authors said.
September 2019

Highlights

Real-time continuous glucose monitoring (CGM), with either an insulin pump or multiple daily injections, was associated with sustained improvements in HbA1c levels compared to self-monitoring of blood glucose, according to a small randomized trial.
October 2019

Highlights

In a longitudinal study of 21,531 patients, those in poor or intermediate health at age 75 years were more likely to use insulin than those in good health (29.4% and 27.5% versus 10.5%, respectively) and less likely to discontinue it during follow-up
October 2019

Highlights

Patients with diabetes and obesity who had metabolic surgery were matched in a 1:5 ratio to those who received usual care, with incidence of a major cardiovascular event (MACE) as the primary outcome.
September 2019

Highlights

An industry-sponsored phase 3 trial found statistically significant improvements in HbA1c level among patients with type 2 diabetes who had inadequate glycemic control on insulin glargine and were randomly assigned to subcutaneous tirzepatide once
February 2022

Highlights

While we could not determine causality between insulin and mortality, we highlight a vulnerable population which needs additional resources in the discharge transition period,” the authors wrote.
March 2019

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next